2020 VC Landscape: Reviewing The First Six Months
Despite Global Disruption Due To COVID-19, Biopharma And Medtech Investors Remain Active
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
